ANN ARBOR, Mich., July 25, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced Dr. Bonnie Bragdon, Vice President of Marketing and Veterinary Affairs, will speak during two sessions at AVMA Convention 2019 on Sunday, August 4, at the Walter E.… Read More..

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Myomo®, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, was recently a featured presenter at the United Brachial Plexus Network’s Camp UBPN, a worldwide initiative striving to inform and… Read More..

Neurocognitive development of youngest patients preserved 12-18 months post treatment; development scores remain within range of unaffected children Robust and sustained biomarker improvement across all dose cohorts with 8 months to 2 years of follow up RMAT meeting anticipated for 2H2019 to discuss next steps NEW YORK and CLEVELAND, July… Read More..